The cell biology of transforming growth factor β
JA Barnard, RM Lyons, HL Moses - … et Biophysica Acta (BBA)-Reviews on …, 1990 - Elsevier
The TGFβ family of polypeptide growth factors regulates a remarkable diversity of cellular
functions, many of which are not directly associated with cell growth. The present review has …
functions, many of which are not directly associated with cell growth. The present review has …
The reproductive significance of human Fallopian tube cilia
RA Lyons, E Saridogan… - Human reproduction …, 2006 - academic.oup.com
Effective tubal transport of ova, sperm and embryos is a prerequisite for successful spontaneous
pregnancy. Although there is much yet to be discovered about the mechanisms involved…
pregnancy. Although there is much yet to be discovered about the mechanisms involved…
Intervention of phytohormone pathways by pathogen effectors
K Kazan, R Lyons - The Plant Cell, 2014 - academic.oup.com
The constant struggle between plants and microbes has driven the evolution of multiple
defense strategies in the host as well as offense strategies in the pathogen. To defend …
defense strategies in the host as well as offense strategies in the pathogen. To defend …
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
Background Measurement of the global burden of disease with disability-adjusted life-years
(DALYs) requires disability weights that quantify health losses for all non-fatal …
(DALYs) requires disability weights that quantify health losses for all non-fatal …
[HTML][HTML] A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
…, E Hexner, RM Lyons, R Paquette… - … England Journal of …, 2012 - Mass Medical Soc
Background Ruxolitinib, a selective inhibitor of Janus kinase (JAK) 1 and 2, has clinically
significant activity in myelofibrosis. Methods In this double-blind trial, we randomly assigned …
significant activity in myelofibrosis. Methods In this double-blind trial, we randomly assigned …
Order flow and exchange rate dynamics
… {r}$$ and $$\sigma ^{2}_{C}$$ (see the working paper version of this article [Evans and Lyons
… Estimates using ΔP t produce results nearly identical to those we report (R 2 's, coefficient …
… Estimates using ΔP t produce results nearly identical to those we report (R 2 's, coefficient …
The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013
…, R Leung, R Lunevicius, RA Lyons… - Injury …, 2016 - injuryprevention.bmj.com
Background The Global Burden of Diseases (GBD), Injuries, and Risk Factors study used
the disability-adjusted life year (DALY) to quantify the burden of diseases, injuries, and risk …
the disability-adjusted life year (DALY) to quantify the burden of diseases, injuries, and risk …
[BOOK][B] The Classification of the Finite Simple Groups, Number 5: The generic case, stages 1-3a
D Gorenstein, R Lyons, R Solomon - 1994 - books.google.com
… Without loss we may assume that e normalizes Q, and we prove the conclusion with R =
Q. We choose an involution 2 e Q such that the pumpup (z, I) of (a, K) in Co(z) is nontrivial; …
Q. We choose an involution 2 e Q such that the pumpup (z, I) of (a, K) in Co(z) is nontrivial; …
[BOOK][B] Probability on trees and networks
… writing was done by Lyons. Exceptions include especially … Lyons was responsible for all
other aspects of authorship of … translate Theorem 1.5 into a probabilistic form (Lyons, 1990): …
other aspects of authorship of … translate Theorem 1.5 into a probabilistic form (Lyons, 1990): …
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
DJ Kuter, JB Bussel, RM Lyons, V Pullarkat… - The Lancet, 2008 - thelancet.com
Background Chronic immune thrombocytopenic purpura (ITP) is characterised by accelerated
platelet destruction and decreased platelet production. Short-term administration of the …
platelet destruction and decreased platelet production. Short-term administration of the …